ATA172385A - Verfahren zur herstellung neuer naphthoxazine - Google Patents

Verfahren zur herstellung neuer naphthoxazine

Info

Publication number
ATA172385A
ATA172385A AT851723A AT172385A ATA172385A AT A172385 A ATA172385 A AT A172385A AT 851723 A AT851723 A AT 851723A AT 172385 A AT172385 A AT 172385A AT A172385 A ATA172385 A AT A172385A
Authority
AT
Austria
Prior art keywords
naphthoxazine
producing new
producing
new
new naphthoxazine
Prior art date
Application number
AT851723A
Other languages
English (en)
Other versions
AT394717B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA172385A publication Critical patent/ATA172385A/de
Application granted granted Critical
Publication of AT394717B publication Critical patent/AT394717B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT0172385A 1984-06-12 1985-06-10 Verfahren zur herstellung neuer naphthoxazine AT394717B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3421729 1984-06-12
DE3508263 1985-03-08

Publications (2)

Publication Number Publication Date
ATA172385A true ATA172385A (de) 1991-11-15
AT394717B AT394717B (de) 1992-06-10

Family

ID=25822036

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0172385A AT394717B (de) 1984-06-12 1985-06-10 Verfahren zur herstellung neuer naphthoxazine

Country Status (28)

Country Link
US (1) US4656167A (de)
JP (1) JPS611676A (de)
AT (1) AT394717B (de)
AU (1) AU582751B2 (de)
BE (1) BE902600A (de)
CA (1) CA1285561C (de)
CH (1) CH666031A5 (de)
CY (1) CY1581A (de)
DE (1) DE3520104C2 (de)
DK (1) DK172306B1 (de)
ES (1) ES8704469A1 (de)
FI (1) FI86301C (de)
FR (1) FR2565586B1 (de)
GB (1) GB2160200B (de)
GR (1) GR851418B (de)
HK (1) HK11891A (de)
HU (1) HU193979B (de)
IE (1) IE58398B1 (de)
IL (1) IL75468A (de)
IT (1) IT1200079B (de)
LU (1) LU85941A1 (de)
MY (1) MY102059A (de)
NL (1) NL194166C (de)
NZ (1) NZ212358A (de)
PH (1) PH23666A (de)
PT (1) PT80634B (de)
SE (1) SE465428B (de)
SG (1) SG9691G (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
HU214591B (hu) * 1989-12-14 1998-04-28 Novartis Ag. Eljárás egy naftoxazinszármazék malonátsójának és az ilyen hatóanyagot tartalmazó gyógyszerkészítmények előállítására
DE4329776A1 (de) * 1993-09-03 1995-03-09 Sandoz Ag Naphthoxazine, ihre Herstellung und Verwendung
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
JP2011525893A (ja) * 2008-06-27 2011-09-29 ハー・ルンドベック・アクチエゼルスカベット 新規のフェノールアミン類およびカテコールアミン類ならびにそのプロドラッグ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2194421B1 (de) * 1972-08-03 1975-10-17 Cerpha
AU521527B2 (en) * 1979-09-12 1982-04-08 Dow Chemical Company, The Dehydrohalogenation of (polyhaloalkyl) benzenes
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
DE4003262A1 (de) * 1990-02-03 1991-08-08 Sandoz Ag Neues naphthoxazin, seine herstellung und verwendung

Also Published As

Publication number Publication date
CY1581A (en) 1992-04-03
IT1200079B (it) 1989-01-05
SE8502865D0 (sv) 1985-06-10
BE902600A (fr) 1985-12-06
FI852325L (fi) 1985-12-13
US4656167A (en) 1987-04-07
FR2565586A1 (fr) 1985-12-13
DE3520104C2 (de) 1997-01-23
JPS611676A (ja) 1986-01-07
LU85941A1 (fr) 1986-01-24
IL75468A (en) 1989-05-15
NZ212358A (en) 1989-01-27
GB8514636D0 (en) 1985-07-10
PH23666A (en) 1989-09-27
GB2160200A (en) 1985-12-18
GB2160200B (en) 1988-03-16
HK11891A (en) 1991-02-22
ES544074A0 (es) 1987-04-01
CA1285561C (en) 1991-07-02
NL8501526A (nl) 1986-01-02
AU582751B2 (en) 1989-04-13
DK259185D0 (da) 1985-06-10
IE851437L (en) 1985-12-12
FR2565586B1 (fr) 1989-09-15
SE8502865L (sv) 1985-12-13
HU193979B (en) 1987-12-28
AT394717B (de) 1992-06-10
SE465428B (sv) 1991-09-09
DK172306B1 (da) 1998-03-09
CH666031A5 (de) 1988-06-30
NL194166C (nl) 2001-08-03
DE3520104A1 (de) 1985-12-12
AU4345885A (en) 1985-12-19
GR851418B (de) 1985-11-25
FI852325A0 (fi) 1985-06-11
FI86301B (fi) 1992-04-30
PT80634B (pt) 1987-10-20
JPH0576472B2 (de) 1993-10-22
PT80634A (en) 1985-07-01
DK259185A (da) 1985-12-13
IL75468A0 (en) 1985-10-31
MY102059A (en) 1992-03-31
HUT39438A (en) 1986-09-29
SG9691G (en) 1991-04-05
FI86301C (fi) 1992-08-10
IT8548195A0 (it) 1985-06-11
IE58398B1 (en) 1993-09-08
ES8704469A1 (es) 1987-04-01
NL194166B (nl) 2001-04-02

Similar Documents

Publication Publication Date Title
AT373599B (de) Verfahren zur herstellung neuer rifamycinderivate
ATA115486A (de) Verfahren zur herstellung neuer antibiotischer makrolite
AT389302B (de) Verfahren zur herstellung neuer 3-benzylidencamphersulfonamidderivate
AT388735B (de) Verfahren zur herstellung neuer cephalosporinverbindungen
AT386208B (de) Verfahren zur herstellung neuer carbapenemzwischenverbindungen
ATA337185A (de) Verfahren zur herstellung neuer flavolignanderivate
ATA233086A (de) Verfahren zur herstellung neuer peptidantibiotika
ATA124285A (de) Verfahren zur herstellung neuer iminothiazolidinderivate
ATA335685A (de) Verfahren zur herstellung neuer thienopyridinderivate
ATA172385A (de) Verfahren zur herstellung neuer naphthoxazine
ATA444982A (de) Verfahren zur herstellung neuer bisindolalkaloidderivate
ATA371584A (de) Verfahren zur herstellung neuer cephalosporanderivate
ATA110680A (de) Verfahren zur herstellung neuer o-trimethyl- silyl-cellulosen
AT376217B (de) Verfahren zur herstellung neuer 3-chlorchinolinderivate
ATA222981A (de) Verfahren zur herstellung neuer alkoxyalkanoylcarnitinhydrohalogeniden
ATA178085A (de) Verfahren zur herstellung von 1-thiosubstituierten n-methyl-2-nitroaethenaminen
ATA215987A (de) Verfahren zur herstellung neuer chinazolinonverbindungen
AT386210B (de) Verfahren zur herstellung neuer 4-carbamoyloxyoxa-zaphosphorine
AT376657B (de) Verfahren zur herstellung neuer thiocarnitine
ATA252985A (de) Verfahren zur herstellung von
ATA143885A (de) Verfahren zur herstellung neuer chinolinderivate
AT388558B (de) Verfahren zur herstellung neuer pyranoderivate
ATA86285A (de) Verfahren zur herstellung neuer thiazolderivate
AT380885B (de) Verfahren zur herstellung neuer organophosphonothioderivate
ATA292686A (de) Verfahren zur herstellung neuer quaternaerer aminthiolverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee